What Causes Uterine Atrophy?

Oct 10, 2021 Source: Cainiu Health
Dr. Lv Aiming
Introduction
1. Physiological atrophy: Uterine physiological atrophy refers to the natural shrinkage of the uterus that occurs at a certain stage of development due to aging, declining endocrine function, or loss of endocrine activity—for example, uterine atrophy commonly occurs in women after menopause. 2. Pathological atrophy: Uterine atrophy occurring under pathological conditions—such as premature ovarian failure—which leads to endocrine insufficiency and subsequently causes uterine atrophy.

Uterine atrophy refers to the degeneration of ovarian function, resulting in decreased estrogen levels and subsequent atrophy of the internal genital organs. A common clinical example is premature ovarian failure, which can lead to uterine atrophy and amenorrhea.

1_Copy1 (4).jpg

What Causes Uterine Atrophy?

1. Physiological Atrophy

Physiological uterine atrophy occurs during specific developmental stages due to aging, declining endocrine function, or complete loss of endocrine activity. For instance, postmenopausal women commonly experience uterine atrophy, often accompanied by atrophy of other tissues such as the gonads, mammary glands, and external genitalia. During perimenopause, organ function declines significantly, making this period the primary phase for physiological uterine atrophy.

2. Pathological Atrophy

Pathological uterine atrophy arises from underlying disease processes. Premature ovarian failure, for example, leads to endocrine insufficiency and consequent uterine atrophy. This condition may also be associated with systemic organ atrophy, potentially caused by prolonged starvation, malnutrition, or malignancy. Therefore, identifying the underlying cause promptly and initiating appropriate treatment are essential for pathological atrophy.

Uterus1.jpg

Additional Information: How to Manage Uterine Atrophy

1. Pharmacological Treatment

Hormone replacement therapy (HRT) is the first-line treatment, typically using natural steroidal estrogen preparations. Commonly prescribed agents include estradiol valerate, conjugated estrogens, estradiol, and estriol. Patients should ensure adequate rest, maintain good personal hygiene, adhere strictly to prescribed medication regimens, and follow their physician’s instructions closely.

2. Dietary Management

Patients should adopt a well-balanced, nutrient-rich diet, emphasizing iron-rich foods. Close monitoring of vital signs and fluid intake/output is necessary. Severely anemic patients require bed rest. Comprehensive diagnostic evaluations must be supported, and meticulous perineal hygiene maintained—including frequent changes and washing of undergarments.

The above outlines the causes of uterine atrophy. We hope this information is helpful to you.

Related Articles

View All